Pricing Log in Create free account
Saturday 17 October 2026 Export ISRG’s income statement to Excel — free account

Intuitive Surgical, Inc.

ISRG Healthcare Medical Instruments & Supplies

Intuitive Surgical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.1 billion, up 20.5% from fiscal 2024. In the quarter to June 2026, revenue grew 18.5%, EPS grew 25.5% and free cash flow grew 69.3%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for five consecutive years, operating cash flow growth for three.

426.70 1.16 −0.27%
Market cap
$151.2B
P/E
48.3×
Fwd P/E
46.4×
Dividend yield
—
F-score
7/9
Altman Z
50.09
Beneish M
−2.43
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Intuitive Surgical, Inc. (ISRG) Revenue

Alert me on Revenue

Intuitive Surgical, Inc.'s revenue for fiscal 2025 was $10.1B, up 20.5% from $8.4B in fiscal 2024. Over the twelve months to 30 June 2026 it was $11.0B. Over the past ten years it has ranged from $2.4B (fiscal 2015) to $10.1B (fiscal 2025) — the current reading is the highest in ten years. Revenue has risen for 5 consecutive fiscal years. Intuitive Surgical, Inc. ranks 4th of 50 Medical Instruments & Supplies companies by revenue.

Revenue, annual

Embed this chart

Annual newest first

Period Revenue Change
FY2025 $10.1B 20.51%
FY2024 $8.4B 17.24%
FY2023 $7.1B 14.49%
FY2022 $6.2B 8.97%
FY2021 $5.7B 31.01%
FY2020 $4.4B (2.68%)
FY2019 $4.5B 20.25%
FY2018 $3.7B 18.67%
FY2017 $3.1B 15.95%
FY2016 $2.7B 13.51%

Quarterly newest first

Period Revenue Change
Jun 2026 $2.9B 4.39%
Mar 2026 $2.8B (3.33%)
Dec 2025 $2.9B 14.41%
Sep 2025 $2.5B 2.67%
42 more quarters

Against its own ten years

Low $2.4B High $10.1B
Ten-year median $4.5B
Current reading's percentile 100

Revenue against peers

Company Revenue
MDLN Medline Inc. compare $29.7B
BDX Becton, Dickinson and Company compare $22.4B
BAX Baxter International Inc. compare $11.5B
ISRG Intuitive Surgical, Inc. $11.0B
ALC Alcon compare $10.9B
SOLV Solventum Corporation compare $8.3B
RMD ResMed Inc. compare $5.7B
WST West Pharmaceutical Services, Inc. compare $3.3B
RGEN Repligen Corporation compare $785.1M

What Revenue is

Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.

Reported line item

The full definition of Revenue →

More on ISRG